Analysts raise Fifth Third targets on positive outlook
Wells Fargo, Morgan Stanley, JP Morgan, and Evercore ISI Group raised price targets for Fifth Third Bancorp, maintaining positive ratings. UBS analyst Erika Najarian also maintained a Buy rating and increased the price target to $65 from $60.

*this image is generated using AI for illustrative purposes only.
Wells Fargo, Morgan Stanley, JP Morgan, and Evercore ISI Group have all raised their price targets for Fifth Third Bancorp (NYSE: FITB), maintaining positive ratings on the stock. The adjustments reflect a revised outlook on the financial institution's stock performance potential. Additionally, UBS has updated its stance on the company.
Wells Fargo analyst Mike Mayo maintained an Overweight rating and raised the price target to $67 from $58. Separately, Morgan Stanley analyst Manan Gosalia maintained an Overweight rating with a price target of $64, up from a previous target of $60.
JP Morgan analyst Vivek Juneja also maintained an Overweight rating, raising the price target from $54.5 to $61. Additionally, Evercore ISI Group analyst John Pancari maintained an In-Line rating and raised the price target from $58 to $60.
UBS analyst Erika Najarian maintained Fifth Third Bancorp with a Buy rating and raised the price target from $60 to $65.
| Firm | Analyst | Rating | Previous Price Target | New Price Target |
|---|---|---|---|---|
| Wells Fargo | Mike Mayo | Overweight | $58 | $67 |
| Morgan Stanley | Manan Gosalia | Overweight | $60 | $64 |
| JP Morgan | Vivek Juneja | Overweight | $54.5 | $61 |
| Evercore ISI Group | John Pancari | In-Line | $58 | $60 |
| UBS | Erika Najarian | Buy | $60 | $65 |
Fifth Third Bancorp continues to carry an Overweight recommendation from Wells Fargo, Morgan Stanley, and JP Morgan, while Evercore ISI Group maintains an In-Line rating and UBS maintains a Buy rating.
What specific factors are driving the unanimous optimism among analysts regarding Fifth Third Bancorp's future performance?
How might Fifth Third Bancorp's upcoming earnings report impact these revised price targets?
What risks could potentially derail the positive outlook set by these analysts?




























